tiprankstipranks
Trending News
More News >
TuHURA Biosciences (HURA)
NASDAQ:HURA
US Market

TuHURA Biosciences (HURA) Ratios

Compare
975 Followers

TuHURA Biosciences Ratios

HURA's free cash flow for Q2 2025 was $0.00. For the 2025 fiscal year, HURA's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.83 3.68 1.16 5.13 0.79
Quick Ratio
0.83 3.64 1.16 5.13 0.79
Cash Ratio
0.56 2.37 1.02 4.96 0.78
Solvency Ratio
-1.02 -4.01 -4.92 -3.11 -0.93
Operating Cash Flow Ratio
-1.02 -2.76 -3.32 -2.61 -0.92
Short-Term Operating Cash Flow Coverage
-35.66 0.00 0.00 0.00 -10.19
Net Current Asset Value
$ -2.63M$ 14.24M$ -1.76M$ 11.85M$ -1.47M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.01 0.54 <0.01 0.10
Debt-to-Equity Ratio
0.03 0.01 -1.50 0.01 -0.86
Debt-to-Capital Ratio
0.03 0.01 2.98 0.01 -6.21
Long-Term Debt-to-Capital Ratio
0.00 0.00 3.04 0.00 0.00
Financial Leverage Ratio
1.78 1.37 -2.80 1.24 -8.56
Debt Service Coverage Ratio
-17.93 -4.21 -1.56K 0.00 -4.72
Interest Coverage Ratio
-34.01 -4.26 -1.59K 0.00 -11.53
Debt to Market Cap
<0.01 0.00 0.99 0.00 <0.01
Interest Debt Per Share
0.02 0.23 5.62 2.99 0.03
Net Debt to EBITDA
0.46 0.71 0.05 1.48 0.82
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
87.81%100.00%100.00%100.00%100.00%
EBT Per EBIT
99.44%122.85%98.50%94.30%96.71%
Return on Assets (ROA)
-44.84%-108.59%-672.13%-61.64%-109.59%
Return on Equity (ROE)
-157.24%-148.57%1880.80%-76.13%938.26%
Return on Capital Employed (ROCE)
-91.41%-120.58%-3888.72%-80.60%970.15%
Return on Invested Capital (ROIC)
-89.41%-119.28%-3785.74%-79.84%6992.69%
Return on Tangible Assets
-121.23%-108.59%-672.13%-61.64%-109.59%
Earnings Yield
-18.53%-28.41%-1252.27%-2.40%>-0.01%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.00 0.04 0.00 0.00 0.00
Inventory Turnover
0.00 0.54 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
0.00 -9.19K 0.00 0.00 0.00
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 671.45 0.00 0.00 0.00
Days of Payables Outstanding
0.00 9.86K 0.00 0.00 0.00
Operating Cycle
0.00 671.45 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.35 -0.79 -28.43 -162.22 -0.16
Free Cash Flow Per Share
-0.35 -0.79 -28.62 -163.00 -0.16
CapEx Per Share
<0.01 <0.01 0.19 5.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-209.65 -254.35 -150.85 -32.36 -2.00K
Capital Expenditure Coverage Ratio
-222.23 -254.35 -150.85 -32.36 -2.00K
Operating Cash Flow Coverage Ratio
-27.69 -72.72 -5.10 -54.32 -10.19
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-16.25%-19.37%-513.87%-1.93%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-5.40 -3.52 -0.08 -41.70 -187.12K
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
4.31 5.23 -1.50 31.75 -1.76M
Price-to-Free Cash Flow (P/FCF) Ratio
-6.16 -5.16 -0.19 -51.78 -199.94K
Price-to-Operating Cash Flow Ratio
-5.41 -5.18 -0.20 -52.03 -200.04K
Price-to-Earnings Growth (PEG) Ratio
-0.05 0.04 >-0.01 >-0.01 1.87K
Price-to-Fair Value
4.31 5.23 -1.50 31.75 -1.76M
Enterprise Value Multiple
-5.11 -3.67 -0.04 -39.38 -218.58K
Enterprise Value
87.73M 63.88M 1.02M 376.54M 1.31T
EV to EBITDA
-5.11 -3.67 -0.04 -39.38 -218.58K
EV to Sales
0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-5.64 -4.32 -0.08 -49.91 -199.94K
EV to Operating Cash Flow
-5.67 -4.34 -0.09 -50.15 -200.04K
Tangible Book Value Per Share
-0.05 0.78 -3.71 265.83 -0.02
Shareholders’ Equity Per Share
0.44 0.78 -3.71 265.83 -0.02
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
0.00 0.00 0.00 0.00 0.00
Net Income Per Share
-0.35 -1.16 -69.75 -202.39 -0.17
Tax Burden
0.88 1.00 1.00 1.00 1.00
Interest Burden
1.03 1.24 1.00 0.94 1.10
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.64 0.68 0.41 0.80 0.94
Currency in USD